TherapeuticsMD | TXMD - Sales Revenues

Stock Price
2.19
Daily Change
0.08 3.79%
Monthly
0.92%
Yearly
121.21%
Q2 Forecast
2.01

TherapeuticsMD reported $234K in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 67.33M 65.44M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Grifols EUR 2.34B 33.3M Mar/2026
Novo Nordisk DKK 12.53B 560M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
TherapeuticsMD USD 234K 79K Jun/2024